MENU

IKT Inhibikase Therapeutics Forecast, Technical & Fundamental Analysis

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated... Show more

IKT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
IKT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

IKT is expected to report earnings to -10 cents per share on November 16

Inhibikase Therapeutics IKT Stock Earnings Reports
Q3'26
Est.
$-0.11
Q2'26
Est.
$-0.11
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.08
Q3'25
Beat
by $0.01
The last earnings report on August 11 showed earnings per share of -10 cents, meeting the estimate of -10 cents. With 203.18K shares outstanding, the current market capitalization sits at 300.00M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1000 N. West Street
Phone
+1 302 295-3800
Employees
35
Web
https://www.inhibikase.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
REEF.X0.0000520.000002
+4.97%
Reef cryptocurrency
TRIBE.X0.407768-0.011181
-2.67%
Tribe cryptocurrency
SPELL.X0.000089-0.000004
-3.84%
Spell Token cryptocurrency
XVS.X3.236334-0.133169
-3.95%
Venus cryptocurrency
STRK.X0.038315-0.004067
-9.60%
Starknet cryptocurrency

IKT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with VIR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
-6.93%
VIR - IKT
34%
Loosely correlated
-3.57%
MLYS - IKT
34%
Loosely correlated
-8.54%
BNTC - IKT
33%
Loosely correlated
-10.23%
EDIT - IKT
33%
Poorly correlated
-7.88%
ACRV - IKT
32%
Poorly correlated
-4.19%
More
Inhibikase Therapeutics (IKT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com